Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huanggang Saikang Pharmaceutical is a China-based active pharmaceutical ingredient manufacturer focused on commercial production of small-molecule APIs and pharmaceutical intermediates. Public company profiles indicate it was founded in 2005 and markets products including melatonin, tauroursodeoxycholic acid, anethole trithione, metronidazole, secnidazole, piribedil, tadalafil, and esomeprazole magnesium. The company appears to operate GMP-certified manufacturing for selected APIs and positions itself as a supplier to the pharmaceutical and chemical markets rather than as a clinical-stage drug developer. Its footprint is centered in Huanggang, Hubei, with manufacturing operations reported in Huangzhou District and a historical site in Macheng. Overall, the company looks best characterized as a commercial Chinese API/pharmaceutical manufacturing company, not a discovery biotech with a disclosed innovative pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huanggang Saikang Pharmaceutical.